These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

804 related items for PubMed ID: 32912782

  • 1. Vascular resection during pancreatectomy for pancreatic head cancer: A technical issue or a prognostic sign?
    Belfiori G, Fiorentini G, Tamburrino D, Partelli S, Pagnanelli M, Gasparini G, Castoldi R, Balzano G, Rubini C, Zamboni G, Crippa S, Falconi M.
    Surgery; 2021 Feb; 169(2):403-410. PubMed ID: 32912782
    [Abstract] [Full Text] [Related]

  • 2. A preoperative risk model for early recurrence after radical resection may facilitate initial treatment decisions concerning the use of neoadjuvant therapy for patients with pancreatic ductal adenocarcinoma.
    Guo SW, Shen J, Gao JH, Shi XH, Gao SZ, Wang H, Li B, Yuan WL, Lin L, Jin G.
    Surgery; 2020 Dec; 168(6):1003-1014. PubMed ID: 32321665
    [Abstract] [Full Text] [Related]

  • 3. Impact of Margin Status on Survival in Patients with Pancreatic Ductal Adenocarcinoma Receiving Neoadjuvant Chemotherapy.
    Schmocker RK, Delitto D, Wright MJ, Ding D, Cameron JL, Lafaro KJ, Burns WR, Wolfgang CL, Burkhart RA, He J.
    J Am Coll Surg; 2021 Apr; 232(4):405-413. PubMed ID: 33338577
    [Abstract] [Full Text] [Related]

  • 4. Predictive factors for long-term survival after surgery for pancreatic ductal adenocarcinoma: Making a case for standardized reporting of the resection margin using certified cancer center data.
    Weyhe D, Obonyo D, Uslar VN, Stricker I, Tannapfel A.
    PLoS One; 2021 Apr; 16(3):e0248633. PubMed ID: 33735191
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Comparison of 4- and 4 plus-courses S-1 administration as adjuvant chemotherapy for pancreatic ductal adenocarcinoma.
    Li B, Shen S, You S, Zhang G, Gao S, Shi X, Wang H, Yin X, Xu X, Guo S, Jin G.
    BMC Cancer; 2021 May 26; 21(1):612. PubMed ID: 34034684
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Surgical therapy of pancreatic cancer - 5 years survival].
    Loveček M, Skalický P, Klos D, Neoral Č, Ehrmann J, Zapletalová J, Švébišová H, Yogeswara T, Ghothim M, Vrba R, Havlík R.
    Rozhl Chir; 2015 Nov 26; 94(11):470-6. PubMed ID: 26766155
    [Abstract] [Full Text] [Related]

  • 10. Survival Trends for Resectable Pancreatic Cancer Using a Multidisciplinary Conference: the Impact of Post-operative Chemotherapy.
    Syed AR, Carleton NM, Horne Z, Dhawan A, Bedi G, Kochhar G, Morrissey S, Williams H, Atkinson D, Schiffman S, Monga D, Lupetin A, Kirichenko A, Mitre M, Dhawan M, Kulkarni A, Thakkar S.
    J Gastrointest Cancer; 2020 Sep 26; 51(3):836-843. PubMed ID: 31605289
    [Abstract] [Full Text] [Related]

  • 11. Outcome of superior mesenteric-portal vein resection during pancreatectomy for borderline ductal adenocarcinoma: results of a prospective comparative study.
    Selvaggi F, Mascetta G, Daskalaki D, dal Molin M, Salvia R, Butturini G, Cellini C, Bassi C.
    Langenbecks Arch Surg; 2014 Jun 26; 399(5):659-65. PubMed ID: 24777762
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of preoperative prognostic factors in patients with resectable invasive intraductal papillary mucinous carcinoma.
    Izumo W, Higuchi R, Furukawa T, Yazawa T, Uemura S, Shiihara M, Yamamoto M.
    Surgery; 2020 Dec 26; 168(6):994-1002. PubMed ID: 32139141
    [Abstract] [Full Text] [Related]

  • 13. A single center experience in resectable pancreatic ductal adenocarcinoma : the limitations of the surgery-first approach. Critical review of the literature and proposals for practice update.
    Dumont R, Puleo F, Collignon J, Meurisse N, Chavez M, Seidel L, Gast P, Polus M, Loly C, Delvenne P, Meunier P, Hustinx R, Deroover A, Detry O, Louis E, Martinive P, Van Daele D.
    Acta Gastroenterol Belg; 2017 Dec 26; 80(4):451-461. PubMed ID: 29560639
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Poorly differentiated resectable pancreatic cancer: is upfront resection worthwhile?
    Crippa S, Partelli S, Zamboni G, Barugola G, Capelli P, Inama M, Bassi C, Pederzoli P, Falconi M.
    Surgery; 2012 Sep 26; 152(3 Suppl 1):S112-9. PubMed ID: 22766365
    [Abstract] [Full Text] [Related]

  • 16. Temporal Assessment of Prognostic Factors in Patients With Pancreatic Ductal Adenocarcinoma Undergoing Neoadjuvant Treatment and Resection.
    Ren W, Xourafas D, Ashley SW, Clancy TE.
    J Surg Res; 2021 Jan 26; 257():605-615. PubMed ID: 32947122
    [Abstract] [Full Text] [Related]

  • 17. Adjuvant chemotherapy after surgery for pancreatic ductal adenocarcinoma: retrospective real-life data.
    Chikhladze S, Lederer AK, Kousoulas L, Reinmuth M, Sick O, Fichtner-Feigl S, Wittel UA.
    World J Surg Oncol; 2019 Nov 09; 17(1):185. PubMed ID: 31706323
    [Abstract] [Full Text] [Related]

  • 18. Risk of Venous Thromboembolism for Patients with Pancreatic Ductal Adenocarcinoma Undergoing Preoperative Chemotherapy Followed by Surgical Resection.
    Boone BA, Zenati MS, Rieser C, Hamad A, Al-Abbas A, Zureikat AH, Hogg ME, Neal MD, Zeh HJ.
    Ann Surg Oncol; 2019 May 09; 26(5):1503-1511. PubMed ID: 30652227
    [Abstract] [Full Text] [Related]

  • 19. Pancreatic adenocarcinoma with venous involvement: is up-front synchronous portal-superior mesenteric vein resection still justified? A survey of the Association Française de Chirurgie.
    Delpero JR, Boher JM, Sauvanet A, Le Treut YP, Sa-Cunha A, Mabrut JY, Chiche L, Turrini O, Bachellier P, Paye F.
    Ann Surg Oncol; 2015 May 09; 22(6):1874-83. PubMed ID: 25665947
    [Abstract] [Full Text] [Related]

  • 20. Nodal downstaging as a treatment goal for node-positive pancreatic cancer.
    Portuondo JI, Massarweh NN, Zhang Q, Chai CY, Tran Cao HS.
    Surgery; 2019 Jun 09; 165(6):1144-1150. PubMed ID: 30745009
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.